Literature DB >> 32615573

Induced Pluripotent Stem Cells for the Treatment of Liver Diseases: Novel Concepts.

Jia Yao1,2, Yue Yu3, Scott L Nyberg4.   

Abstract

Millions of people worldwide with incurable liver disease die because of inadequate treatment options and limited availability of donor organs for liver transplantation. Regenerative medicine as an innovative approach to repairing and replacing cells, tissues, and organs is undergoing a major revolution due to the unprecedented need for organs for patients around the world. Induced pluripotent stem cells (iPSCs) have been widely studied in the field of liver regeneration and are considered to be the most promising candidate therapies. This review will conclude the current state of efforts to derive human iPSCs for potential use in the modeling and treatment of liver disease.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Blastocyst complementation; Induced pluripotent stem cells; Liver diseases; Liver transplantation; Regeneration medicine

Mesh:

Year:  2020        PMID: 32615573      PMCID: PMC7775900          DOI: 10.1159/000508182

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.208


  2 in total

1.  Identification of key pathways and hub genes in the myogenic differentiation of pluripotent stem cell: a bioinformatics and experimental study.

Authors:  Wenyong Fei; Mingsheng Liu; Yao Zhang; Shichao Cao; Xuanqi Wang; Bin Xie; Jingcheng Wang
Journal:  J Orthop Surg Res       Date:  2021-01-04       Impact factor: 2.359

Review 2.  Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production.

Authors:  Ellen L Larson; Dong Jin Joo; Erek D Nelson; Bruce P Amiot; Rajagopal N Aravalli; Scott L Nyberg
Journal:  Stem Cell Reports       Date:  2021-10-21       Impact factor: 7.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.